Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genetic Screens02:46

Genetic Screens

5.8K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.8K
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

434
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
434
Drug Discovery: Overview01:26

Drug Discovery: Overview

12.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Macrophage-Derived PDGF-BB and GDF-15 Promote Drug Resistance in KRAS-Mutant Colorectal Cancer.

bioRxiv : the preprint server for biology·2026
Same author

Functional Exploration of African Colorectal Cancer Patients Using Personalised <i>Drosophila</i> Avatars.

bioRxiv : the preprint server for biology·2026
Same author

Chemical programming of kinase inhibitors in a modular chemputer-based system.

Communications biology·2026
Same author

WNT signalling promotes NF-κB activation and drug resistance in KRAS-mutant colorectal cancer.

EMBO reports·2025
Same author

Colon cancer cells evade drug action by enhancing drug metabolism.

Oncogene·2025
Same author

Functional exploration of copy number alterations in a Drosophila model of triple-negative breast cancer.

Disease models & mechanisms·2024
Same journal

Electrical coupling between transplanted cardiomyocytes and host myocardium to prevent arrhythmia.

Disease models & mechanisms·2026
Same journal

Leucettinib-21 decreases dosage effects of DYRK1A in human trisomy 21 induced pluripotent stem cell-derived neural cells.

Disease models & mechanisms·2026
Same journal

Mesoscale maladaptation in disease organoids.

Disease models & mechanisms·2026
Same journal

A modeller's guide for biomedical discovery.

Disease models & mechanisms·2026
Same journal

An antioxidant therapy elicits distinct transcriptome responses in 22q11-deleted upper layer cortical projection neurons.

Disease models & mechanisms·2026
Same journal

Co-mutations of CTNNB1 and PTEN drive aggressive tumor progression in endometrial cancer.

Disease models & mechanisms·2026
See all related articles

Related Experiment Video

Updated: Mar 12, 2026

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
17:28

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation

Published on: June 17, 2015

13.2K

Drug screening using model systems: some basics.

Ross Cagan1

  • 1Icahn School of Medicine at Mount Sinai, Annenberg 25-40, Campus Box 1020, 1468 Madison Avenue, New York, NY 10029, USA ross.cagan@mssm.edu.

Disease Models & Mechanisms
|November 9, 2016
PubMed
Summary
This summary is machine-generated.

Laboratories screening drug candidates must understand the complex path to clinical application. Researching lead hits, patentable chemical space, and druggability is crucial before initiating screening.

More Related Videos

A Manual Small Molecule Screen Approaching High-throughput Using Zebrafish Embryos
07:45

A Manual Small Molecule Screen Approaching High-throughput Using Zebrafish Embryos

Published on: November 8, 2014

18.3K
Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery
07:45

Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery

Published on: March 4, 2021

4.0K

Related Experiment Videos

Last Updated: Mar 12, 2026

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
17:28

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation

Published on: June 17, 2015

13.2K
A Manual Small Molecule Screen Approaching High-throughput Using Zebrafish Embryos
07:45

A Manual Small Molecule Screen Approaching High-throughput Using Zebrafish Embryos

Published on: November 8, 2014

18.3K
Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery
07:45

Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery

Published on: March 4, 2021

4.0K

Area of Science:

  • Pharmacology
  • Medicinal Chemistry
  • Drug Discovery

Background:

  • Model system laboratories are increasingly involved in drug screening initiatives.
  • Transitioning initial drug screening hits to clinical development presents significant challenges.
  • A specialized knowledge base and mindset are required for successful clinical translation.

Discussion:

  • Thorough preliminary research is essential before commencing drug screening.
  • Key concepts such as 'lead hits', 'patentable chemical space', and 'druggability' require careful consideration.
  • Navigating the drug screening process effectively involves understanding these critical factors.

Key Insights:

  • Early-stage homework significantly impacts the success of drug development pipelines.
  • Understanding 'druggability' and 'patentable chemical space' guides strategic screening decisions.
  • Lessons learned from navigating the screening matrix can de-risk the drug development process.

Outlook:

  • Future drug discovery efforts will benefit from integrating early-stage strategic planning.
  • Enhanced understanding of pre-clinical and clinical translation pathways is needed.
  • This editorial provides a framework for laboratories to optimize their drug screening strategies.